P3: Infrared Irradiation and Scleroderma Skin
P3: Infrared Irradiation and Scleroderma Skin
批准号:
7483078
负责人:
Sewon Kang
金额:
$3.69万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-08-01 至 2011-07-31
关键词:
AffectAfrican AmericanAsiansBiopsyCellsClinical TrialsCollagenComplexControlled Clinical TrialsCutaneousCutaneous InvolvementDataDependenceDepositionDermalDermisDevicesDiseaseDoseEnd PointEnrollmentFibrillar CollagenFibrosisFundingHispanicsHumanIndividualInhibition of Matrix Metalloproteinases PathwayInterleukin-4Interleukin-6KidneyLearningLifeLocalized sclerodermaLungMatrix MetalloproteinasesMedicalMetabolismModalityMorbidity - disease ratePatientsPersonal SatisfactionPigmentation physiologic functionPigmentsPilot ProjectsProcollagenProductionProtocols documentationReactionReaction TimeResearch DesignSafetySclerodermaSignal TransductionSkinSkin CancerSkin PigmentationSolidSourceSunburnSurfaceSystemic SclerodermaTemperatureTestingTherapeuticTherapy Clinical TrialsTimeTreatment EfficacyTreatment ProtocolsUltraviolet B RadiationUnited States National Institutes of Healthbasecancer riskconnective tissue growth factorcytokineimprovedin vivoirradiationskin colorultravioletultraviolet irradiation
中文摘要
皮肤中过多的胶原沉积是硬皮病的标志。目前没有安全与/或
英文摘要
Excessive collagen deposition in the skin is a hallmark of scleroderma. Currently there are no safe and/or
effective therapies. Excessive accumulation of collagen is responsible for the markedly thickened and hard
feel to the involved skin of scleroderma. Therefore, a therapy that can safely enhance collagen breakdown
is expected to improve it. We have accumulated solid evidence that UV irradiation of human skin activates a
complex signaling cascade in cells that ultimately results in a several fold increase in the amount of matrix
metalloproteinases (MMPs) with consequent degradation of collagen, while simultaneously inhibiting new
procollagen synthesis. Thus, by removing already present dermal collagen and suppressing production of
new collagen, UV is capable of causing a net collagen loss in human skin. As a phototherapeutic device
however, both UVB (290-320nm) and UVA1 (340-400nm) have significant limitations. More energetic UVB
is associated with sunburn reaction, and its carcinogenic potential is well established. UVA1 is safer and
better tolerated by human skin. However, we have learned that both natural and UV-induced skin
pigmentation are effective blockers of UVA1. Scleroderma affects subjects with all levels of skin
pigmentation (types I-VI). An antifibrotic treatment modality that is not influenced by skin color will offer a
significant medical advancement, especially in darkly pigmented African American, Hispanic, Indian, or Asian
patients (types V&VI). Our preliminary data indicate that infrared irradiation (IR; specifically 700-4,000nm)
that raises skin surface temperature to 41 degrees C is capable of safely inducing MMPs and inhibiting procollagen
irrespective of human skin pigmentation. Thus we hypothesize that IR will also improve scleroderma and
other fibrotic diseases. We propose to 1) fully characterize the ability of IR to reduce collagen in normal skin,
and 2) obtain preliminary data of the IR effect on scleroderma skin. The data generated with the assistance
of RDCC will form the basis for an application to the NIH to fund a multicenter IR therapeutic trial in
scleroderma.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
OPEN LABEL STUDY OF TETRATHIOMOLYBDATE IN TREATMENT OF PSORIASIS VULGARIS
-
批准号:7199915
-
项目类别:
-
资助金额:$0.67万
-
财政年份:2005
-
负责人:Sewon Kang
-
依托单位:
University of Michigan Multidisciplinary Clinical Research (RMI)
-
批准号:7288723
-
项目类别:
-
资助金额:$17.63万
-
财政年份:2005
-
负责人:Sewon Kang
-
依托单位:
Univ of Michigan Multidisciplinary Clinical Resea**(RMI)
-
批准号:7050494
-
项目类别:
-
资助金额:$67.14万
-
财政年份:2005
-
负责人:Sewon Kang
-
依托单位:
University of Michigan Multidisciplinary Clinical Research (RMI)
-
批准号:7169521
-
项目类别:
-
资助金额:$67.03万
-
财政年份:2005
-
负责人:Sewon Kang
-
依托单位:
UV-induced collagen reduction: treating skin scleroderma
-
批准号:6789958
-
项目类别:
-
资助金额:$37.75万
-
财政年份:2001
-
负责人:Sewon Kang
-
依托单位:
UV-Induced Collagen Reduction--Treating Skin Scleroderma
-
批准号:6407566
-
项目类别:
-
资助金额:$37.75万
-
财政年份:2001
-
负责人:Sewon Kang
-
依托单位:
UV-induced collagen reduction: treating skin scleroderma
-
批准号:6512141
-
项目类别:
-
资助金额:$37.75万
-
财政年份:2001
-
负责人:Sewon Kang
-
依托单位:
UV-induced collagen reduction: treating skin scleroderma
-
批准号:6915175
-
项目类别:
-
资助金额:$37.75万
-
财政年份:2001
-
负责人:Sewon Kang
-
依托单位:
UV-induced collagen reduction: treating skin scleroderma
-
批准号:6605012
-
项目类别:
-
资助金额:$37.75万
-
财政年份:2001
-
负责人:Sewon Kang
-
依托单位:
CLINICAL TRANSLATIONAL RESEARCH IN DERMATOLOGY
-
批准号:6532924
-
项目类别:
-
资助金额:$12.31万
-
财政年份:2000
-
负责人:Sewon Kang
-
依托单位:
CLINICAL TRANSLATIONAL RESEARCH IN DERMATOLOGY
-
批准号:6778160
-
项目类别:
-
资助金额:$12.31万
-
财政年份:2000
-
负责人:Sewon Kang
-
依托单位:
CLINICAL TRANSLATIONAL RESEARCH IN DERMATOLOGY
-
批准号:6085893
-
项目类别:
-
资助金额:$12.31万
-
财政年份:2000
-
负责人:Sewon Kang
-
依托单位:
CLINICAL TRANSLATIONAL RESEARCH IN DERMATOLOGY
-
批准号:6374353
-
项目类别:
-
资助金额:$12.31万
-
财政年份:2000
-
负责人:Sewon Kang
-
依托单位:
CLINICAL TRANSLATIONAL RESEARCH IN DERMATOLOGY
-
批准号:6650380
-
项目类别:
-
资助金额:$12.31万
-
财政年份:2000
-
负责人:Sewon Kang
-
依托单位:
ABX IL8 IN TREATMENT OF MODERATE TO SEVERE PLAQUE PSORIASIS
-
批准号:6263685
-
项目类别:
-
资助金额:$0.02万
-
财政年份:1998
-
负责人:Sewon Kang
-
依托单位:
ABX IL8 IN TREATMENT OF MODERATE TO SEVERE PLAQUE PSORIASIS
-
批准号:6297042
-
项目类别:
-
资助金额:$0.02万
-
财政年份:1998
-
负责人:Sewon Kang
-
依托单位:
BG9273 (LFA3/IGG1 FUSION PROTEIN) IN PATIENTS WITH CHRONIC PSORIASIS
-
批准号:6274783
-
项目类别:
-
资助金额:$2.15万
-
财政年份:1997
-
负责人:Sewon Kang
-
依托单位:
SAFETY AND EFFICACY OF ORAL RAPAMYCIN IN THE TREATMENT OF RECALCITRANT PSORIASIS
-
批准号:6244611
-
项目类别:
-
资助金额:$2.22万
-
财政年份:1997
-
负责人:Sewon Kang
-
依托单位:
STUDY OF HU1124 IN MODERATE TO SEVERE PLAQUE PSORIASIS
-
批准号:6274759
-
项目类别:
-
资助金额:$2.15万
-
财政年份:1997
-
负责人:Sewon Kang
-
依托单位:
PHASE I STUDY OF BMS188667 (CTLA4IG) IN PATIENTS WITH PSORIASIS VULGARIS
-
批准号:6274648
-
项目类别:
-
资助金额:$2.15万
-
财政年份:1997
-
负责人:Sewon Kang
-
依托单位:
海外基金